NCT04400474 2025-06-19CABATENGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed93 enrolled 17 charts
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 4 FDA
NCT00002608 2013-07-10Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed30 enrolled
NCT00019331 2013-06-20Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed